Long-term outcomes of elective thoracic endovascular aortic repair (TEVAR) for degenerative thoracic aortic aneurysms (TAA) are not well defined. A review of the literature on the follow-up outcomes of elective TEVAR for degenerative TAA resulted in 22 relevant articles. Two- and five-year freedom from aneurysm-related death varied between 93.0% and 100.0%, and 82.4% to 92.7%, respectively. Two-year and five-year all-cause survival ranged between 68.0% and 97.2% and 47.0% to 78.0%, respectively. Follow-up ranged between 17.3 and 66.0 months. Most common endograft-related complication was endoleak, with reported rate between 1.4% and 14.8% during six months up to five years of follow-up. Endovascular reinterventions were reported in 0.0–32.3%, secondary open surgery was needed in 0.0% to 4.7% during follow-up. Aneurysm-related survival rates after elective TEVAR for degenerative TAA are acceptable. However, reported incidences of endograft-related complications vary considerably in the literature, but the majority can be managed with conservative treatment or additional endovascular procedures.
OrandiBJDimickJBDeebGM. A population-based analysis of endovascular versus open thoracic aortic aneurysm repair. J Vasc Surg2009; 49: 1112–1116.
2.
StroupDFBerlinJAMortonSC. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA2000; 283: 2008–2012.
3.
BavariaJEAppooJJMakarounMS. Endovascular stent grafting versus open surgical repair of descending thoracic aortic aneurysms in low-risk patients: a multicenter comparative trial. J Thorac Cardiovasc Surg2007; 133: 369–377.
4.
ChaikofELMutrieCKasirajan. Endovascular repair for diverse pathologies of the thoracic aorta: an initial decade of experience. J Am Coll Surg2009; 208: 802–816. discussion 16–18.
5.
CzernyMFunovicsMSodeckG. Long-term results of thoracic endovascular aortic repair in atherosclerotic aneurysms involving the descending aorta. J Thorac Cardiovasc Surg2010; 140: S179–184. discussion S85–S90.
6.
FairmanRMTuchekJMLeeWA. Pivotal results for the Medtronic Valiant Thoracic Stent Graft System in the VALOR II trial. J Vasc Surg2012; 56: 1222–1231 e1.
7.
FoleyPJCriadoFJFarberMA. Results with the talent thoracic stent graft in the VALOR trial. J Vasc Surg2012; 56: 1214–1221 e1.
8.
GladeGJVahlACWisselinkW. Mid-term survival and costs of treatment of patients with descending thoracic aortic aneurysms; endovascular vs. open repair: a case-control study. Eur J Vasc Endovasc Surg: Off J Eur Soc Vasc Surg2005; 29: 28–34.
9.
HassounHTMitchellRSMakarounMS. Aortic neck morphology after endovascular repair of descending thoracic aortic aneurysms. J Vasc Surg2006; 43: 26–31.
10.
MakarounMSDillavouEDKeeST. Endovascular treatment of thoracic aortic aneurysms: results of the phase II multicenter trial of the GORE TAG thoracic endoprosthesis. J Vasc Surg2005; 41: 1–9.
11.
MakarounMSDillavouEDWheatleyGH. Five-year results of endovascular treatment with the Gore TAG device compared with open repair of thoracic aortic aneurysms. J Vasc Surg2008; 47: 912–918.
12.
MarcheixBDambrinCBolducJP. Midterm results of endovascular treatment of atherosclerotic aneurysms of the descending thoracic aorta. J Thorac Cardiovasc Surg2006; 132: 1030–1036.
13.
MoralesJPGreenbergRKLuQ. Endoleaks following endovascular repair of thoracic aortic aneurysm: etiology and outcomes. J Endovasc Ther: Off J Int Soc Endovasc Special2008; 15: 631–638.
14.
ParmerSSCarpenterJPEndologixI. Endovascular aneurysm repair with suprarenal vs infrarenal fixation: a study of renal effects. J Vasc Surg2006; 43: 19–25.
15.
Scharrer-PamlerRKotsisTKapferX. Complications after endovascular treatment of thoracic aortic aneurysms. J Endovasc Ther: Off J Int Soc Endovasc Special2003; 10: 711–718.
16.
SchoderMCartes-ZumelzuFGrabenwogerM. Elective endovascular stent-graft repair of atherosclerotic thoracic aortic aneurysms: clinical results and midterm follow-up. AJR Am J Roentgenol2003; 180: 709–715.
17.
YunokiJKurataniTShirakawaY. Mid-term results of endovascular treatment with the Gore TAG device for degenerative descending thoracic aortic aneurysms. Gen Thorac Cardiovasc Surg2015; 63: 38–42.
18.
DemersPMillerDCMitchellRS. Midterm results of endovascular repair of descending thoracic aortic aneurysms with first-generation stent grafts. J Thorac Cardiovasc Surg2004; 127: 664–673.
19.
DesaiNDBurtchKMoserW. Long-term comparison of thoracic endovascular aortic repair (TEVAR) to open surgery for the treatment of thoracic aortic aneurysms. J Thorac Cardiovasc Surg2012; 144: 604–609. discussion 9–11.
20.
KarimiAWalkerKLMartinTD. Midterm cost and effectiveness of thoracic endovascular aortic repair versus open repair. Ann Thorac Surg2012; 93: 473–479.
21.
LeeCJRodriguezHEKibbeMR. Secondary interventions after elective thoracic endovascular aortic repair for degenerative aneurysms. J Vasc Surg2013; 57: 1269–1274.
22.
PattersonBHoltPNienaberC. Aortic pathology determines midterm outcome after endovascular repair of the thoracic aorta: report from the Medtronic Thoracic Endovascular Registry (MOTHER) database. Circulation2013; 127: 24–32.
23.
von AllmenRSAnjumAPowellJT. Outcomes after endovascular or open repair for degenerative descending thoracic aortic aneurysm using linked hospital data. Br J Surg2014; 101: 1244–1251.
24.
ConradMFErgulEAPatelVI. Management of diseases of the descending thoracic aorta in the endovascular era: a Medicare population study. Ann Surg2010; 252: 603–610.
25.
LindholtJSSorensenHTMichelJB. Low-dose aspirin may prevent growth and later surgical repair of medium-sized abdominal aortic aneurysms. Vasc Endovasc Surg2008; 42: 329–334.
26.
SteinLHBergerJTranquilliM. Effect of statin drugs on thoracic aortic aneurysms. Am J Cardiol2013; 112: 1240–1245.
